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Salmonella produce microRNA-like 
RNA fragment Sal-1 in the infected 
cells to facilitate intracellular 
survival
Hongwei Gu1,2, Chihao Zhao1,2, Tianfu Zhang1,2, Hongwei Liang1,2, Xiao-Ming Wang1, Yi 
Pan1,2, Xi Chen1,2, Quan Zhao1,2, Donghai Li1,2, Fenyong Liu3, Chen-Yu Zhang1,2 & Ke Zen1,2
Salmonella have developed a sophisticated machinery to evade immune clearance and promote survival 
in the infected cells. Previous studies were mostly focused on either bacteria itself or host cells, the 
interaction mechanism of host-pathogen awaits further exploration. In the present study, we show 
that Salmonella can exploit mammalian cell non-classical microRNA processing machinery to further 
process bacterial small non-coding RNAs into microRNA-like fragments. Sal-1, one such fragment with 
the highest copy number in the infected cells, is derived from Salmonella 5′-leader of the ribosomal RNA 
transcript and has a ‘stem’ structure-containing precursor. Processing of Sal-1 precursors to mature 
Sal-1 is dependent on host cell Argonaute 2 (AGO2) but not Dicer. Functionally, depleting cellular Sal-1 
strongly renders the Salmonella bacteria less resistant to the host defenses both in vitro and in vivo. 
In conclusion, we demonstrate a novel strategy for Salmonella evading the host immune clearance, in 
which Salmonella produce microRNA-like functional RNA fragments to establish a microenvironment 
facilitating bacterial survival.
Salmonella spp. remains a leading cause of food-borne illness in the world. Salmonella, an enterobacteriaceae 
(rod-shaped, facultative intracellular parasites), infects both human and animals, each year causing approxi-
mately 1.3 billion cases of human diseases ranging from diarrhoea to typhoid fever1. Similar to other highly suc-
cessful pathogens, Salmonella have developed various strategies to invade and survive in host cells2–4, including 
bypassing cellular anti-bacterial pathways1, subverting host innate and adaptive immune responses2, and eventu-
ally replicating inside the host cells3, 4. The strategies used by Salmonella are mainly dependent on bacterial com-
ponents and generally fall into two categories: (a) active modification of its surface molecules (e.g., LPS, flagella, 
and peptidoglycan) to avoid host immune surveillance2, and (b) delivery of effectors into the eukaryotic host cells 
via the secretion systems (such as type III or type IV secretion system) to promote bacterial invasion, survival 
and replication inside the host cells4–7. After internalization, Salmonella can enter into the membrane-enclosed 
compartments (vacuoles and modified phagosomes) where they are protected from host defense mechanisms. In 
those compartments, Salmonella multiply freely before being released from the host cell to infect other cells. The 
ability to occupy such protected intracellular niche contributes to the pathogenesis of S. enterica8.
It has been widely reported that unlike dead bacteria, living bacteria can release functional RNAs and proteins 
into the cytosol after they enter into the host cells4, 9, 10. Although the mechanism remains unclear, the delivery 
of bacterial materials into the cytosol of host cells is likely through active secretion or passive leakage out of the 
phagolysosome. In the cytosol, bacterial RNA can activate the host defenses. For example, Sander et al.11 showed 
that released bacterial RNA in the host cell cytosol bind to the receptors triggering a host response against the 
bacteria. Studying the mechanism underlying the vulnerability of Listeria monocytogenes to host defense, Schoen 
et al.9 showed that the released ovalbumin-encoding mRNA into the cytosol of epithelial cells, macrophages, and 
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dendritic cells by that strain of Listeria was quickly processed and presented in MHC I molecules. In contrast 
to the ways in which bacterial mRNA can trigger host defenses against infecting bacteria, small non-coding 
RNA released by Salmonella and other pathogenic bacteria have recently emerged as mechanisms protecting the 
bacteria. These small non-coding RNA enable the bacteria to adapt to host environmental perturbations such as 
change in pH, osmotic pressure, as well as enabling intracellular replication12, 13. However, it remains unknown 
whether or how these small non-coding RNA can directly affect host cells by modulating mammalian cell gene 
expression in response to bacterial infection.
In the present study, we show that Salmonella can release small non-coding RNAs into the cytosol of the 
infected human intestinal epithelial cells, and within the host cell cytosol, these Salmonella RNA transcripts are 
further processed into ~22 nt miRNA-like functional RNA segments by AGO2-based non-classical miRNA pro-
cessing machinery. One such RNA segment, Sal-1, has the highest copy number and can promote the intracellular 
survival of Salmonella in the infected cells. The present study thus identifies Sal-1 as a novel virulence factor for 
facilitating bacterial intracellular survival.
Results
Detection of Salmonella-encoded small RNA fragments in the infected mammalian 
cells. Using the Solexa sequencing technique, we surveyed the global miRNA expression profile in intesti-
nal epithelial HT-29 cells infected with S. enteritidis (strain SE2472). Cell lysate was centrifuged at high-speed 
and passed through a 0.22-μm filter to remove bacterial cells. In addition to a significantly altered expression 
profile of host cell endogenous miRNAs compared with that in the mock-infected cells, a panel of ~22-nt small 
RNA fragments derived from Salmonella were detected in Salmonella- infected cells (GEO accession number: 
GSE53586). The sequences and reads of these small RNA fragments (≥100 reads in Solexa sequencing) are listed 
in Supplemental Table S1. The copy number of Sal-1 was similar to that of endogenous miR-107. The sequences 
of these RNA segments did not match with the human genome but completely matched with Salmonella genome, 
suggesting that they were encoded by Salmonella and conserved in various Salmonella strains. Interestingly, size 
analysis of these Salmonella-specific RNA fragments detected by Solexa sequencing showed a predominant dis-
tribution around 22 nt, a typical length of miRNA (Fig. 1a). The expression levels of five fragments (≥200 reads 
in Solexa sequencing) were further assayed by qRT-PCR with customised TaqMan probes. As shown in Fig. 1b, 
these fragments were detected in Salmonella-infected HT-29 cells but not in mock-infected cells. As the most 
enriched fragment, Sal-1 was assayed in other cell types infected with different Salmonella strains. Similar levels 
of Sal-1 were detected in HeLa and RAW264.7 cells infected with either SE2472 or Salmonella reference strain 
ST14028S (Fig. 1c). Production of Sal-1 in Salmonella-infected HT-29 was in a dose- and time-dependent manner 
Figure 1. Production of small RNA fragments encoded by Salmonella in human intestinal epithelial cells 
infected by Salmonella strain SE2472. (a) Size distribution of Salmonella-encoded small RNA fragments. (b) 
Levels of five Salmonella-encoded small RNA fragments in HT-29 cells infected by SE2472. (c) Sal-1 level in 
RAW264.7 and HeLa cells infected with various Salmonella strains. (d) Sal-1 level in HT-29 cells at 12 h post-
infection with SE2472 at MOI of 1 (low), 10 (medium) and 100 (high), respectively. (e) Sal-1 level in HT-29 
cells at 6, 12 and 24 h post-infection with SE2472. The data are presented as the mean ± SEM (n = 4). ND, not 
detected.
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(Fig. 1d and e), suggesting that more replication of bacteria in host cells yields more Sal-1. When HT-29 cells 
were infected with strain SE2472 at different multiplicities of infection (MOI of 1, 10 and 100) and assayed at 
24 h post-infection, higher MOI of bacteria led to more bacteria invasion and more Sal-1 production (Fig. 1d). 
In HT-29 cells infected with strain SE2472 at MOI of 10, Sal-1 level was significantly increased from 6 h to 24 h 
post-infection (Fig. 1e).
The presence of Sal-1 in Salmonella-infected HT-29 cells was further confirmed by northern blot analy-
sis (Fig. 2a) and qRT-PCR analysis (Fig. 2b), respectively. Interestingly, Sal-1 was only detected in samples of 
Salmonella-infected host cells (Fig. 2a). Salmonella alone (bacteria cultured in LB) only yielded large fragments 
of approximately 300 nt. In contrast, Salmonella-infected HT-29 cells generated not only large fragments but 
also medium and small fragments of ~70 nt and ~25 nt, respectively. The qRT-PCR analysis also confirmed that 
Sal-1 was only detected in Salmonella-infected HT-29 cells but not bacterial culture supernatant (SE2472 SP) 
(Fig. 2b), suggesting that Sal-1 must be processed in the host cells. This is consistent with previous report that 
bacteria themselves can only produce small non-coding RNAs of 50–300 nt but not of 20–24 nt14. In support of 
the observation that Sal-1 can only be generated in the host cells infected by Salmonella, we blocked the entry of 
strain SE2472 into HT-29 cells by INP0403, a small molecule that specifically inhibits T3SS15 and then tested the 
intracellular bacteria and Sal-1 level in HT-29 cells. As can be seen, compared with the DMSO vehicle control, 
INP0403 strongly blocked the entry of Salmonella SE2472 into the HT-29 cells (Fig. 2c), leading to no or little 
production of Sal-1 (Fig. 2d).
Biogenesis of Sal-1 in the infected host cells. We next characterized the biogenesis of Sal-1 in 
Salmonella-infected cells. As shown in Supplementary Fig. 1a and b, Salmonella genome (S. enteritidis P125109) 
contained seven copies of Sal-1, all of which were located at 92 nt upstream of the bacterial 16 S RNA gene in the 
non-coding region. Characterization of these seven Sal-1 copies (sites 1–7) was shown in Supplementary Fig. 2. 
The Sal-1 sequence was highly conserved among Salmonella enterica spp., Escherichia coli, and Shigella spp. The 
Figure 2. Production of mature Sal-1 in the Salmonella-infected intestinal epithelial cells. (a) Northern 
blot detection of Sal-1 in SE2472-infected HT-29 cells. (b) Sal-1 level in LB-grown SE2472, bacteria culture 
supernatant (SP) and HT-29 cells with Mock or SE2472 infection. (c-d) Bacteria number (c) and Sal-1 level (d) 
in the SE2472-infected HT-29 cells treated with or without T3SS blocker INP0403. The data are presented as the 
mean ± SEM (n = 4). ND, not detected. **P < 0.01.
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structure analysis showed that Sal-1 locus was 74 nt in length with two flanking arms of 24 nt for Sal-1 (left arm 
was marked with red frame), 26 nt for 3′ arm which is complementary to the ‘mature’ Sal-1 (marked with green 
frame), and a loop of 24 nt in between. This structure can be folded into a miRNA-like hairpin of Sal-1 ‘precursor’ 
(Pre-Sal-1). We thus speculated that mature Sal-1 (marked in red) could be produced through further digestion of 
two putative hairpin structures of Pre-Sal-1 (named Pre-1 for sites 1–3 and 5–7, and Pre-2 for site 4) (Fig. 3a). The 
sequence difference between Pre-1 and Pre-2 is located at the loop region (at position 47 within Pre-Sal-1 hairpin, 
“U” for Pre-1 and “C” for Pre-2). To confirm that hairpin structures of Pre-Sal-1 can be processed into mature Sal-
1, the complete sequences of Pre-1 or Pre-2 were synthesized and inserted into the pcDNATM6.2-GW/EmGFP 
vector (Fig. 3b). Sal-1-expressing plasmids (Pre-1 and Pre-2) were then transfected into HT-29 cells, and the 
production of Sal-1 was analysed by qRT-PCR and northern blot analysis. As shown in Fig. 3c, Sal-1 was only 
detected by qRT-PCR in HT-29 cells transfected with Pre-1 or Pre-2, but not in non-transfected HT-29 cells or 
Figure 3. Biogenesis of Sal-1 in the Salmonella–infected HT-29 cells is AGO2-dependent. (a) Prediction 
of putative hairpin structure of Pre-Sal-1 for the biogenesis of mature Sal-1. (b) Construction of 
pcDNATM6.2-GW/EmGFP vector expressing Pre-Sal-1. Pre-Sal-1 was inserted immediately downstream of 
GFP and promoted by the CMV promoter. (c,e) Mature Sal-1 in HT-29 cells transfected with two Pre-Sal-1 
expression plasmids (Pre-1 and Pre-2) detected by qRT-PCR (c) and northern blot analysis (e). (d) qRT-PCR 
detection of Sal-1 level in Pre-1- or Pre-2-transfected HT-29 cells with or without Dicer or Ago2 silence. (e) 
Northern blot analysis of Sal-1 in Pre-1- or Pre-2-transfected HT-29 cells with or without Ago2 silence. (f) qRT-
PCR detection of Sal-1 level in SE2472-infected HT-29 cells with or without Dicer or Ago2 silence. (g) Northern 
blot of Sal-1 and Pre-Sal-1 in SE2472-infected HT-29 cells with or without Dicer or Ago2 silence. (h) RT-PCR 
amplification of Pre-Sal-1 and mature Sal-1 that are associated with AGO2 complex in HT-29 cells directly 
infected with SE2472 or transfected with Pre-Sal-1. Pre-Sal-1 was amplified, inserted into a T-vector and 
sequenced. The data are presented as the mean ± SEM (n = 3). **P < 0.01. ND, not detected.
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cells transfected with empty vector (negative control). Northern blot analysis of mature Sal-1 expression con-
firmed that Pre-Sal-1 can be properly processed into Sal-1 in host cells (Fig. 3e).
To test whether the generation of Sal-1 depends on its ‘stem-loop’ structure, we mutated Pre-1 at the 3′ arm 
to disrupt the sequence complementary to mature Sal-1. Although the sequence of mature (Mat) Sal-1 was 
not changed, the free energy of the mutated form of Pre-1 plasmid (Pre-1 Mut) was significantly higher (from 
∆G = −25 kcal/mol to ∆G = −8.4 kcal/mol) (Supplementary Fig. 3a). After transfected into HT-29 cells, north-
ern blot analysis showed that in contrast to Pre-1 WT-transfected cells in which Pre-Sal-1 was rapidly processed 
into Sal-1, cells transfected with Pre-1 Mut had an accumulation of Pre-Sal-1 but a strongly reduced Sal-1 pro-
duction (Supplementary Fig. 3b).
Maturation of Sal-1 in the Salmonella-infected cells is AGO2-dependent. Dicer is widely consid-
ered a central enzyme for cleaving short hairpins in classic miRNA processing16. However, for certain miRNAs 
such as miR-451, AGO2 is responsible for miRNA processing through a non-classical pathway17, 18. To determine 
whether the biogenesis of Sal-1 follows the processing pathways similar to miRNA, we knocked down Dicer or 
AGO2 in HT-29 cells via Dicer- or Ago2-specific siRNA and then determined Sal-1 level in HT-29 cells that were 
transfected with Pre-1 or Pre-2. As shown in Supplementary Fig. 4a and b, levels of Dicer and AGO2 were sig-
nificantly decreased by transfection with Dicer siRNA and Ago2 siRNA, respectively. In agreement with previous 
reports19, 20, level of miR-451 was not affected by Dicer knockdown but was significantly decreased by AGO2 
knockdown (Supplementary Fig. 4c). Similarly, when HT-29 cells were co-transfected with Pre-1 or Pre-2 plus 
Dicer siRNA or Ago2 siRNA, Sal-1 level was significantly decreased by Ago2 siRNA but not Dicer siRNA (Fig. 3d). 
Northern blot analysis also showed that Sal-1 level was decreased by AGO2 knockdown and the reduction of 
Sal-1 was correlated to an accumulation of Pre-1 (Fig. 3e). Together, these results suggest that host cell AGO2 
plays a critical role in the biogenesis of Sal-1.
AGO2-dependence of Sal-1 biogenesis was further confirmed in Salmonella-infected HT-29 cells. As shown in 
Fig. 3f, Sal-1 level in HT-29 cells infected with strain SE2472 was significantly reduced by AGO2 knockdown but 
not Dicer knockdown. Northern blot analysis of Salmonella-infected HT-29 cells treated with control siRNA or 
Dicer siRNA displayed three bands of 200–400 nt, ~70 nt and ~25 nt, likely the ‘primary’ form of Sal-1 (Pri-Sal-1), 
Pre-Sal-1 and mature Sal-1, respectively, whereas in Salmonella-infected HT-29 cells treated with Ago2 siRNA, 
both the medium (~70 nt) and small (~25 nt) bands were significantly downregulated (Fig. 3g). The sequencing 
validation after amplification and insertion into T-vector confirmed that ~70 nt and ~25 nt bands were indeed the 
Sal-1 precursor (Pre-Sal-1) and mature Sal-1, respectively (data not shown).
To confirm the association of Sal-1 precursor or mature Sal-1 with AGO2 complex, we used anti-AGO2 anti-
body to immunoprecipitate AGO2 in HT-29 cells that were transfected with Pre-Sal-1 or infected directly with 
strain SE2472 (Fig. 3h), and then detected Pre-Sal-1 or mature Sal-1 in the immuneprecipitated complex by 
anti-AGO2 antibody. The results showed that both Pre-Sal-1 and mature Sal-1 were associated with the immuno-
precipitated AGO2 complex. The sequence of the ~70 nt band collected from strain SE2472-infected cells com-
pletely matched that of Pre-Sal-1 (Pre-1).
Procedure of process from Pri-Sal-1 to mature Sal-1. To explore the source of Pri-Sal-1 in 
Salmonella-infected HT-29 cells, we performed 3′- and 5′- rapid amplification of cDNA ends (RT-RACE) to 
amplify primary Sal-1 in Salmonella-infected HT-29 cells (Supplementary Fig. 5). RNA was extracted from cell 
lysate that had passed through filter to remove the bacteria. As shown in Fig. 4a, we amplified three Pri-Sal-1 frag-
ments, named Pri-Sal-1A (402 nt), 1B (291 nt), and 1 C (195 nt). These three Pri-Sal-1 fragments were all located 
in the non-coding region just upstream of the 16 S RNA gene, specifically at a distance of 92 nt from the 16 S RNA. 
The difference of three Pri-Sal-1 fragments in size (Pri-Sal-1B and Pri-Sal-1C) or sequence (Pri-Sal-1A) was likely 
due to their different location within Salmonella genome since Sal-1 could be transcribed from 7 different sites. 
The characterisation of Pri-Sal-1A, −1B and −1C in bacterial species was shown in Supplemental Tables S2–4. 
To confirm the AGO2-dependence of Sal-1 biogenesis, all three Pri-Sal-1 fragments were cloned into the pGEM-
11Zf(+) vector, digested at the 3′-end, and transcribed by T7 RNA polymerase into primary Sal-1 RNA that were 
then transfected into HT-29 cells. As shown by northern blot (Fig. 4b) and qRT-PCR analysis (Fig. 4c and d), all 
the primary Sal-1 transcription fragments were successfully digested into Pre-Sal-1 and mature Sal-1, respec-
tively, whereas the expression levels of Pre-Sal-1 (Fig. 4c) and mature Sal-1 (Fig. 4d) were significantly decreased 
when the cells were co-transfected with Ago2 siRNA.
Sal-1 increases the intracellular survival rate of Salmonella. Given the stable expression of Sal-1 
in host cells and its positive correlation with Salmonella infection, we next explored the potential role of Sal-1 
in the process of Salmonella infection. In the experiment, HT-29 cells were transfected with anti-Sal-1 oligo-
nucleotide (Anti-Sal-1) to deplete cellular Sal-1 prior to Salmonella infection. As shown in Fig. 5a and c, the 
dose- or time-dependent increase of Sal-1 level in Salmonella-infected HT-29 cells, and Sal-1 was eliminated 
with anti-Sal-1 oligonucleotide. Depletion of cellular Sal-1 strongly reduced intracellular survival rate of strain 
SE2472 (Fig. 5b and d). These results collectively suggest that Sal-1 is involved in facilitating bacterial replication 
and survival in the infected cells.
To confirm the production of Sal-1 by Salmonella-infected cells and further test its role in bacterial intra-
cellular survival, we employed “the Red Recombination System” to generate mutated SE2472 strain with Sal-1 
sites being deleted. Given that deletion of all seven Sal-1 sites significantly impaired the bacterial growth, we 
generated a mutated SE2472 strain with only four Sal-1 sites being deleted, termed as SE2472∆Sal-1(1,2,5,7) 
(Supplementary Fig. 6). Strain SE2472∆Sal-1(1,2,5,7) displayed a similar growth curve in LB with strain SE2472 
(Fig. 6a), suggesting that deletion of four Sal-1 sites in strain SE2472 does not affect bacterial growth. As expected, 
compared to WT strain SE2472, strain SE2472∆Sal-1(1,2,5,7) produced significantly less Sal-1 in HT-29 cells 
www.nature.com/scientificreports/
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(Fig. 6b). Infection with strain SE2472∆Sal-1(1,2,5,7) resulted in a lower intracellular survival rate of bacteria 
compared to the WT SE2472 strain, and recovered with Sal-1(Fig. 6c).
Sal-1 enhances Salmonella infection in mice. We next tested the role of Sal-1-targeting iNOS in 
Salmonella infection using mouse model. For this purpose, we constructed a Sal-1-expressing lentivirus vector 
(LV-Sal-1) to deliver Sal-1 in mouse colon tissues. In addition, a lentivirus vector containing three sequences 
that are completely complementary to Sal-1 was also constructed as a molecular sponge (LV-Sal-1 sponge) to 
absorb Sal-1. As depicted in Fig. 7a, mice were pre-treated with lentivirus vector (LV-Sal-1 or LV-Sal-1 sponge) 
or control lentivirus vector (LV-NTC). On the day 3, mice were then intragastrically infected with strain SE2472 
(6 × 105 CFU/ml). After euthanized mice on day 6, the mouse colon tissues were analysed for the levels of Sal-1 
and bacterial intracellular survival. Sal-1 level in colon tissue was significantly elevated in Salmonella-infected 
mice compared with non-infected mice (Fig. 7b). The level of Sal-1 in Salmonella-infected colon tissues was 
further increased when the mice were treated with LV-Sal-1 but was markedly decreased when the mice were 
treated with LV-Sal-1 sponge. As an intracellular bacterial pathogen, infected Salmonella replicates in the intes-
tinal epithelium. We thus determined the colonization levels of Salmonella in mouse colon tissues. As shown in 
Fig. 7c, colonies of Salmonella were detected in all the Salmonella-infected mice, whereas no Salmonella colonies 
were detected in the Mock infection group. The CFU counts in the strain SE2472-infected mice were significantly 
increased by LV-Sal-1 treatment but decreased by LV-Sal-1 sponge treatment. Together, these results suggest that 
increase of cellular level of Sal-1 promotes while depletion of cellular Sal-1 suppresses Salmonella intracellular 
survival.
Figure 4. Identification of ‘primary’ form of Sal-1 in SE2472-infected HT-29 cells, which can be processed into 
pre-Sal-1 and mature Sal-1 sequentially. (a) Analysis of the sequences of three primary Sal-1 sites consisting 
of non-coding RNA and a partial region of the 5′ terminus of the 16 sRNA. (b) AGO2-dependent of Sal-1 
generation from 3 possible Pri-Sal-1 (A, B and C) in HT-29 cells. Pri-Sal-1 (A, B and C) were amplified from 
infected HT-29 cells with 3′- and 5′- RT-RACE cDNA amplification followed by insertion into a pGEM-11Zf(+) 
vector for in vitro transcription. These primary Sal-1 RNA transcription fragments were then transfected into 
HT-29 for pre-Sal-1 and Sal-1 production. (c-d) Levels of pre-Sal-1 (c) and Sal-1 (d) in the pri-Sal-1-transfected 
HT-29 cells with or without silencing Ago2. The data are presented as the mean ± SEM (n = 3). **P < 0.01. ND, 
not detected.
www.nature.com/scientificreports/
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A clinical scoring system, considering the factors, such as motility, ruffled fur, hunched position, feeding, 
ataxia and tremor, was further used to assess the systemic Salmonella infection in BALB/c mice. As shown in 
Fig. 7d, the mice in the mock infection group were completely healthy, with the highest score of 100. In con-
trast, the mice administered strain SE2472 or SE2472 plus control lentivirus vector (SE2472 + LV-NTC) dis-
played moderate illness and showed a clinical score of around 60. The mice administered strain SE2472 plus 
LV-Sal-1 (SE2472 + LV-Sal-1) developed a severe illness with the lowest clinical scores. The illness burden of 
Salmonella infection in mice, however, could be significantly alleviated by treatment with LV-Sal-1 sponge 
(SE2472 + LV-Sal-1 sponge) to deplete cellular Sal-1.
Discussion
The concept that RNA molecules from viral or non-viral pathogens can act as regulators in eukaryotic cells has 
been around for some time. Early work showed that double-stranded RNA expressed by E. coli can silence genes 
in C. elegans21. Subsequently, enteroinvasive E. coli were engineered to deliver regulatory short hairpin RNA 
(shRNA) molecules into mammalian cells22. Functional mRNAs delivered by engineered Listeria bacteria was 
shown to modulate the immune response of host cells4. Application of high-density tiling array and RNA sequenc-
ing technologies have recently shown that bacteria contain an extensive and previously unidentified repertoire 
of non-coding RNA, including 5′ and 3′ UTRs, antisense transcripts and intergenic small RNAs (sRNAs)23, 24. 
In addition to affecting various functional aspects of the bacteria, certain bacterial non-coding RNAs can also 
interfere with C. elegans genes and impact on the physiology of C. elegans25. Recently Weiberg et al.26 showed 
that fungal “virulent” sRNA can target the gene of plant cells and suppress host immunity. During host-pathogen 
crosstalk, miRNA-mediated regulation has been recently reported27. Samonella engage miRNA to alter the host 
SUMOylome for raising its capacity for intracellular survival28. However, these RNAs mentioned above are all 
large-size RNA fragments, and it remains unknown whether small-size RNAs derived from pathogens have a 
similar posttranscriptional regulatory mechanism to control host gene expression. Against the traditional con-
cept that bacteria cannot produce miRNA, here we demonstrate that, after entry into the host cells, pathogenic 
Salmonella can exploit host atypical miRNA processing machinery to further process its small non-coding RNAs 
into ~22 nt miRNA-like fragments, which in turn, directly regulate host cell gene expression at posttranscriptional 
Figure 5. Sal-1 facilitates the intracellular bacterial survival following Salmonella infection. (a) Depletion of 
cellular Sal-1 by anti-Sal-1 oligonucleotide in HT-29 cells infected with SE2472 at MOI of 1, 10 and 100. (b) 
Bacterial survival rate in HT-29 cells infected with SE2472 at MOI of 1, 10 or 100. (c) Depletion of Sal-1 by anti-
Sal-1 oligonucleotide in HT-29 cells infected with SE2472 for 6, 12 or 24 h. (d) Bacterial survival rate in HT-29 
cells infected with SE2472 for 6, 12 or 24 h. Data are presented as the mean ± SEM (n = 3). ND, not detected. 
**P < 0.01.
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 2392  | DOI:10.1038/s41598-017-02669-1
level. This finding significantly expands the role of bacterial non-coding RNAs in modulating bacteria-host cell 
interplaying. Given that a panel of 19–24 nt milRNA fragments derived from Salmonella can be produced in the 
Salmonella-infected cells (Supplemental Table S1), production of such small functional RNA fragments might 
be a common phenomenon during enterobacteriaceae infection. As such ~22 nt Salmonella RNA fragments like 
Sal-1 can facilitate bacterial intracellular amplification and survival, they may represent novel virulence factors 
that are important for Salmonella infection and intracellular replication.
The endonuclease activity of AGO2 has been shown to play an important role in non-canonical maturation of 
miRNA17–19, 29. As a RNA-induced silencing complex (RISC) slicer, AGO2 plays a role in cleaving the pre-miRNA 
Figure 6. Deletion of Sal-1 sequence in bacterial genome decreases the bacterial intracellular survival rate 
following Salmonella infection. (a) Bacterial growth rate. (b) Level of Sal-1 in HT-29 cells infected with WT 
SE2472 or mutant SE2472∆Sal-1(1,2,5,7). (c) The level of bacterial intracellular survival rate in HT-29 cells 
infected with SE2472 or mutant SE2472∆Sal-1(1,2,5,7). Note that delivery of Sal-1 into SE2472∆Sal-1(1,2,5,7) 
-infected cells via Sal-1-expressing lentivirus largely repairs the defect of SE2472∆Sal-1(1,2,5,7) in promoting 
bacterial survival. ND, not detected. **P < 0.01.
Figure 7. Role of Sal-1 in facilitating Salmonella infection in mice. The lentivirus expressing Sal-1 (LV-Sal-1) 
or Sal-1 sponge (LV-Sal-1 sponge) were constructed to overexpress or deplete Sal-1 in mouse colon epithelium. 
Prior to Salmonella infection, the lentiviruses were slowly administered into the lumen of mouse colon 
via a catheter. Female BALB/c mice (6–8 weeks) were then inoculated intragastrically with Salmonella. (a) 
Experimental design. (b) Sal-1 levels in mouse colon tissues. (c) Salmonella bacteria count in the mouse colon 
tissues. (d) The clinical scores of the mice after Salmonella infection. ND, not detected. **P < 0.01.
www.nature.com/scientificreports/
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hairpin to an additional processing intermediate (termed as AGO2-cleaved precursor miRNA)18. Cleavage of 
pre-miR-451 by AGO2 is critical for maturation of miR-45117. Our result demonstrates that AGO2 actually medi-
ates not only a single but two cleavage steps during maturation of bacterial Sal-1 in Salmonella-infected cells. As 
shown in Fig. 3, AGO2 is responsible for the cleavage of ‘pri-Sal-1′ (200–400 nt) to pre-Sal-1 (74 nt) and pre-Sal-1 
to mature Sal-1 (24 nt). Knockdown of AGO2 resulted in an accumulation of ‘pri-Sal-1′ but less pre-Sal-1 and 
mature Sal-1 in Salmonella-infected cells. Our result suggests that, as an endonuclease, AGO2 might play an 
essential role in processing bacterial small RNA in the host cells. The capacity of AGO2 to cleave RNA fragments 
with various lengths may be due to a relative less strict restriction on the length RNA fragment required by AGO2, 
compared to Dicer.
Given that the production of Sal-1 is dependent on cellular AGO2 complex, bacteria alone cannot produce 
Sal-1. Therefore, although many non-pathogenic bacteria strains such as E. coli also contain Sal-1 sequence in 
their genome, mature Sal-1 will not be produced by the non-pathogenic bacteria strains and function as a viru-
lence factor for them because these bacteria strains cannot enter into the host cells. For pathogenic enterobacte-
riaceae, it has been documented that large bacterial RNA fragments are released from bacteria into the host cells 
following the entry of bacteria into the cells9, 10. Although the mechanism remains unclear, the release of bacterial 
RNA fragments into the cytoplasm may be associated with active secretion and/or passive leakage out of the 
phagolysosome. Our results clearly showed that a 200–400 nt Salmonella RNA fragment, as the primary form of 
Sal-1, was released into the host cell cytoplasm in a time-dependent and dose-dependent manner. Inside the host 
cells, the bacterial Pri-Sal-1 was further processed by AGO2 into Pre-Sal-1 and Sal-1, accordingly.
In addition, we performed Ago2 silence experiments to further explore the link between Ago2 maturation of 
Sal-1 and host sensitivity to Salmonella cells. As shown Supplementary Fig. 7, Ago2 siRNA treatment decreased 
the intracellular survival of both two Salmonella strains. Also, Sal-1 mutant SE2472ΔSal-1(1, 2, 5,7) displayed a 
lower intracellular survival rate than WT SE2472 strain, and the intracellular survival rate of SE2472ΔSal-1(1, 
2, 5,7) was further decreased by Ago2 siRNA treatment. We speculated that AGO2 depletion affect many other 
events, including the all miRNA function in the host cells, so the factors other than Sal-1 may also contribute to 
the decrease of bacterial intracellular survival after AGO2 depletion.
In the present study, we show that Salmonella can exploit mammalian cell AGO2-mediated non-classical 
miRNA processing machinery to further process their non-coding RNA fragment of ribosomal or transfer RNA 
transcript into ~22 nt milRNA fragments. Specifically, in the infected host cells, Salmonella can process the frag-
ment of the 5′ leader of bacterial ribosomal RNA operon transcript into 24 nt Sal-1, which in turn, facilitates 
the intracellular amplification and survival of Salmonella. Thus, the milRNA fragments like Sal-1, produced by 
Salmonella in the infected cells, may represent a novel class of virulence factors associated with bacterial infection 
and intracellular survival, and its potential pathogenic mechanism waiting for further study.
Materials and Methods
Cells, reagents and antibodies. Human intestinal epithelial cells (HT-29) and Hela were purchased from 
the China Cell Culture Centre (Shanghai, China) and maintained at 37 °C in a humidified 5% CO2 incubator with 
RPMI-1640 medium (Gibco, Carlsbad, CA) containing 10% FBS (Gibco), 100 units/ml penicillin, and 100 μg/
ml streptomycin. Human embryonic kidney (HEK-293T) and mouse RAW264.7 cells (ATCC) were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS. Cell transfection was performed 
using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA). The anti-AGO2 (ab57113 for IP, and ab32381 for WB), 
anti-Dicer (ab14601), Normal mouse IgG was purchased from Millipore (Cat. 12–371). Synthetic RNA molecules, 
including Dicer and Ago2 siRNA, antagomir anti-Sal-1 (2′-OMe-modified, cholesterol-conjugated), and scram-
bled control oligonucleotides, were purchased from GenePharma (Shanghai, China). Oligonucleotide probes 
containing locked nucleic acids (LNA, Exiqon) used for the Northern blot and DIG non-radioactive nucleic acid 
labelling and detection were purchased from Roche.
Bacteria strains and invasion assay. Highly virulent WT Salmonella enteritidis strain SE247230 (the iso-
late with low LD50 (<103 organisms) and mortality occurred rapidly) was grown in Luria-Bertani (LB) broth. E. 
coli strains Top 10 and DH5α were used as hosts to amplify the plasmids. The cell invasion assay was performed 
as described previously30. Briefly, for the infection, HT-29 or RAW264.7 cells were seeded in six-well cell culture 
plates (Costar, Corning, NY) in culture medium without antibiotics. The bacteria were inoculated in 2 ml of LB 
medium and incubated at 37 °C overnight without shaking. The bacterial suspensions were diluted to a multi-
plicity of infection (MOI) of approximately five to ten. The plates were centrifuged at 1,000 rpm for 5 min and 
incubated at 37 °C for 2 h. After extensive washing, cell culture medium with gentamicin (50 μg/ml) was added, 
and the plates were incubated for 1.5 h at 37 °C. Next, the cells were washed five times, culture medium with 
gentamicin (10 μg/ml) was added, and the plates were incubated for 6, 12 or 24 h. The cells were then washed and 
lysed in 1 ml of phosphate-buffered saline (PBS) with 0.1% Triton X-100. The lysates were pipetted vigorously to 
release the intracellular bacteria, which were removed by filtering through a 0.22-μm membrane. A ten-fold dilu-
tion series was performed for the lysates, and they were plated onto LB plates for incubation overnight at 37 °C. 
The number of CFUs on the plates were counted and compared with the number of input bacteria. The invasive-
ness of Salmonella was measured by determining the percentage of intracellular bacteria, which was calculated 
as: number of intracellular bacteria/number of input bacteria) × 100. For S anti-Sal-1 antisense oligonucleotide 
(ASO) treatment, cells were first transfected with anti-Sal-1 ASO via Lipofectamine 2000, then infected with 
Salmonella on the second day. After infection, cells were washed with PBS followed by treatment with medium 
containing 50 μg/mL gentamicin to kill extracellular bacteria for 1.5 h. Cells were continuously cultured in the 
medium containing 10 μg/mL gentamicin for 24 h, and then harvested for assessment of bacterial survival.
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RNA isolation and qRT-PCR. Total RNA was extracted from Salmonella strain SE2472, Salmonella-infected 
cells, or whole tissues using TRIzol reagent or TRIzol LS reagent (Invitrogen) according to the manufacturer’s 
instructions. Quantitative RT-PCR was performed using TaqMan Sal-1 probes (Applied Biosystems, Foster City, 
CA) according to the manufacturer’s instructions. Briefly, total RNA was reverse transcribed to cDNA using AMV 
reverse transcriptase (Takara) and a stem-loop RT primer (Applied Biosystems). Real-time PCR was performed 
using a TaqMan PCR kit and an Applied Biosystems 7300 Sequence Detection System (Applied Biosystems). All 
the reactions, including the no-template controls, were performed in triplicate. After the reaction, the CT values 
were determined using fixed threshold settings. To calculate the absolute expression levels of the target Sal-1, a 
series of synthetic Sal-1 oligonucleotides at known concentrations was reverse transcribed and amplified. The 
absolute amount of each Sal-1 was calculated in reference to the standard curve, or the Sal-1 expression in the 
cells was normalised to the U6 snRNA level.
Solexa sequencing. Solexa sequencing was performed as previously described31. In brief, total RNA was 
extracted from strain SE2472-infected HT-29 cells (which were lysed with PBS containing 0.1% Triton X-100 and 
filtered through a 0.22-μm membranes) using TRIzol LS reagent (Invitrogen, Carlsbad, CA). After polyacryla-
mide gel electrophoresis (PAGE) purification of the small RNA molecules (less than 30 base pairs) and ligation 
of a pair of Solexa adaptors to their 5′ and 3′ ends, the small RNA molecules were amplified using the adaptor 
primers for 17 cycles, and those fragments of approximately 90 bp (small RNA + adaptors) were isolated from the 
PAGE gels. The purified DNA was directly used for cluster generation and sequencing analysis using an Illumina 
Genome Analyzer according to the manufacturer’s instructions. The image files generated by the sequencer were 
then processed to produce digital data. The subsequent procedures included summarising the data produced, 
evaluating the sequencing quality and depth, calculating the length distribution of the small RNAs, and filtering 
contaminated reads.
The full-length cDNA of the Salmonella primary Sal-1. The full-length cDNAs of the Salmonella 
primary Sal-1 were obtained using the SMARTerTM RACE cDNA amplification kit (Clontech, Mountain View, 
CA) according to the manufacturer’s instructions. Because the RNA template was from a prokaryotic organism 
and lacked a polyadenylated tail, we thus added a poly(A) tail using Poly(A) Polymerase (Takara). Then, the 
first-strand cDNA was synthesised using a modified oligo(dT) primer (5′-RACE CDS primer A or 3′-RACE CDS 
primer A), and the SMARTerTM II A oligonucleotide was added for 5′-RACE cDNA synthesis. The gene-specific 
antisense primer sal-GSP1 was used for 5′-RACE amplification, and sal-GSP2 was used for 3′-RACE amplifica-
tion. The cDNA was amplified using the Advantage 2 PCR kit (Clontech) with the above gene-specific primers 
and the Universal Primer A Mix in the SMARTerTM RACE kit. The RACE product was electrophoresed, purified, 
and ligated into the pMD19-T Easy vector (Takara). The ligations were transformed into E. coli Top 10 chemically 
competent cells. The plasmids were extracted from bacterial cell suspensions using the E.Z.N.A.® Plasmid Mini 
Kit (Omega Bio-Tek, Norcross, GA) for sequence analysis.
Cell transfection. HT-29 cells or RAW264.7 macrophages were seeded in 6-well plates or 60-mm dishes 
and transfected using LipofectamineTM 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instruc-
tions. To knock down Dicer or AGO2, their respective active siRNAs or a scrambled negative control was used. 
The sequences of the siRNAs used in this study were listed in Supplementary Table S5. To overexpress Sal-1 or 
Pre-Sal-1 plasmids or a scrambled negative control were used. To transfect Pri-Sal-1, in vitro transcript primary 
Pri-Sal-1 RNAs were used. At 6 h post-transfection, the media was changed to DMEM supplemented with 1% FBS 
and the cells were harvested 48 h post- transfection.
Northern blot analysis. Northern blot analysis was performed on Sal-1 and total RNAs isolated from 
Salmonella strain SE2472, Salmonella-infected cells, and Pri-Sal-1- and Pre-Sal-1-transfected cells. Total RNA 
was dissolved in 2x RNA loading buffer (Takara, Dalian, China), heated at 95 °C for 5 min, loaded onto denatur-
ing 15% TBE-urea PAGE gels, transferred onto nylon membranes, and UV-cross linked with 1200mJ of energy. 
For northern blot analysis, an LNA probe was labelled with the non-radioactive DIG using the End Tailing Kit 
(Roche, Indianapolis, IN). Pre-hybridisation and hybridisation were performed according to the manufacturer’s 
instructions. A DIG-labelled U6 snRNA probe was used as a control. Probe detection was performed using the 
DIG Luminescent Detection Kit. Briefly, the blots were incubated in blocking solution for 30 min and then in 
anti-DIG-AP antibody solution for 30 min, followed by two washes. After equilibration, the blots were incubated 
with the chemiluminescent substrate CDP-Star and exposed to Kodak X-OMAT BT film.
Western blot. The cells were rinsed with PBS and lysed in cold RIPA buffer (10 mM Tris-HCl, 1 mM EDTA, 
1% sodium dodecyl sulphate, 1 mM DTT, 0.1 mM PMSF, protease inhibitors, 1% Nonidet P-40, pH 8.0). Lysates 
were centrifuged at 16,100 × g for 10 min at 4 °C to remove cell debris, and the protein content was analysed using 
a Micro BCA Protein Assay kit (Pierce, Rockford, IL). The proteins (40 μg) were separated by SDS-PAGE and 
electrotransferred to polyvinylidene difluoride (PVDF) membranes (Roche, Indianapolis, IN). The membranes 
were blocked with 5% non-fat dry milk or bovine serum albumin (BSA) in TBST (Tris-buffered saline plus 0.1% 
Tween-20) for 1 h. The blots were then probed with primary antibodies against Dicer, AGO2 or GAPDH, followed 
by horseradish peroxidase-conjugated secondary antibodies. Chemiluminescence detection was performed by 
using the ECL kit (Pierce) or exposure to X-ray film (Kodak).
Detection of Sal-1 and Pre-Sal-1 in AGO2-associated complex. Salmonella-infected or Pre-Sal-
1-transfected cells were lysed with lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 0.5% Nonidet P-40, 2 mM 
EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM PMSF, DNase and RNase inhibitors, and 1% Protease Inhibitor Cocktail, 
pH7.5) for 30 min on ice. The lysates were cleared by centrifugation (16,000 × g) for 10 min at 4 °C and then 
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immunoprecipitated with mouse monoclonal anti-AGO2 antibody or mouse normal IgG followed by protein 
G-agarose beads at 4 °C overnight with shaking. After elution from the beads, the RNA was prepared using 
TRIzol LS reagent. A rabbit polyclonal anti-AGO2 antibody was used for western blot analysis. After purification, 
immunoprecipitated RNA was analysed by real-time RT-PCR for Sal-1 using TaqMan Sal-1 probes (Applied 
Biosystems) according to the manufacturer’s instructions or by semi-quantitative RT-PCR using primers (listed 
in Supplementary Table S5) specific for Pre-Sal-1. The PCR amplification product was collected and inserted into 
T-vector for sequencing.
Construction of a Salmonella mutant with deletion of Sal-1 sequence. A Sal-1 deletion (ΔSal-1) 
mutant of SE2472 was constructed using the one-step mutagenesis method as described previously32. Different 
primers were used to amplify drug resistance genes (such as Kanr, Chlr, Spcr, etc.) from different plasmids (such as 
pKD3, pKD3, pfw5, etc.) replacing the Sal-1 sequence. And plasmid pcp20 was used to remove resistance genes.
In vitro transcription of primary Pri-Sal-1. Primary Pri-Sal-1 RNAs were obtained using Riboprobe® in 
vitro Transcription Systems (Promega) according to the manufacturer’s instructions. The primers were designed 
for the amplification of primary Pri-Sal-1 from Salmonella-infected HT-29 cells according to the sequences 
obtained from 3′- and 5′- RACE amplification. RT-PCR amplification products were inserted into the EcoRI and 
HindIII double-digested pGEM®−11Zf( + ) (Promega) vector and sequenced. These recombinant plasmids were 
then linearized by digestion with HindIII (used for T7 transcription). The template DNA was purified by phenol/
chloroform extraction and used for in vitro transcription. The DNA template was removed by digestion with 
DNase I following the transcription reaction.
In vivo studies. Animal maintenance and experimental procedures were performed in accordance with the 
National Institutes of Health Guidelines for the Use of Experimental Animals and approved by the Animal Care 
Committee of Nanjing University (Nanjing, China). 60 female BALB/c mice (6–8 weeks old) were randomly 
divided into 6 groups, and one group was inoculated with PBS as a Mock infection. Briefly, 0.5–2 × 108 TU of 
lentivirus was slowly administered into the lumens of the mouse colons via a catheter inserted 4 cm into the colon 
through the anus. The mice were inoculated intragastrically with 5 × 106 CFU of strain SE2472 per mouse. The 
mice were monitored during the course of infection, and the clinical evaluation was performed according to a 
clinical scoring system (based on the activity of the mice, their feeding, appearance of their fur, hunched posi-
tioning, and hemorrhagic spots on the tail) as previously described with minor modifications33. The mice were 
euthanized at 3 days after inoculation, and their colons were collected to analyse the Sal-1 expression and the 
surviving Salmonella colonies. Aliquots of mouse colon tissue homogenates were used to determine the CFU/ml 
through serial dilution and plating onto CHROMagarTM plates. The plates were incubated at 37 °C for 18 h. The 
number of Salmonella colonies was counted the next day. Each sample was analysed in triplicate, and the analysis 
was repeated at least twice. The CFU per sample was expressed as the average of the counts obtained. The concen-
trations of bacteria were recorded as CFU per mg of organ.
Statistical analysis. Western blot and qRT-PCR results were representative of at least three independent 
experiments. The data are presented as the mean ± SEM of at least three independent experiments, and the differ-
ences were considered to be statistically significant at P < 0.05 using non-parametric tests or one-way ANOVA.
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